Literature DB >> 8738798

Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney.

R Lapinski1, N Perico, A Remuzzi, F Sangalli, A Benigni, G Remuzzi.   

Abstract

Studies in experimental animals and humans have documented that inhibition of the renin-angiotensin system by angiotensin-converting enzyme inhibitors reduces urinary protein excretion rate and retards the development of renal injury. Here we sought to investigate whether angiotensin II (All) modified the size-selective properties to macromolecules of the glomerular capillary barrier in isolated perfused rat kidney preparation. Compared with basal values, continuous All infusion into the renal artery at the rate of 3 or 8 ng/min, but not at 0.6 ng/min, induced a progressive and significant increase in urinary protein excretion rate. Evaluation of the sieving properties of the glomerular barrier by fractional clearance of polydisperse Ficoll showed that All significantly enhanced the filtration of tracer molecules of radil > or = 34A. All-induced changes in urinary protein excretion rate and in Ficoll fractional clearance were completely prevented by pretreatment with the specific All Type 1 receptor antagonist SR 47436.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738798     DOI: 10.1681/ASN.V75653

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  17 in total

1.  Blood pressure response to conventional and low-dose enalapril in chronic renal failure.

Authors:  Thomas Elung-Jensen; Jens Heisterberg; Anne-Lise Kamper; Jesper Sonne; Svend Strandgaard
Journal:  Br J Clin Pharmacol       Date:  2003-02       Impact factor: 4.335

2.  Congenital nephrotic syndrome responsive to angiotensin-converting enzyme inhibition.

Authors:  Rajasree Sreedharan; Detlef Bockenhauer
Journal:  Pediatr Nephrol       Date:  2005-06-18       Impact factor: 3.714

Review 3.  Podocyte directed therapy of nephrotic syndrome-can we bring the inside out?

Authors:  Janina Müller-Deile; Mario Schiffer
Journal:  Pediatr Nephrol       Date:  2015-05-05       Impact factor: 3.714

4.  Permselective dysfunction of podocyte-podocyte contact upon angiotensin II unravels the molecular target for renoprotective intervention.

Authors:  Daniela Macconi; Mauro Abbate; Marina Morigi; Stefania Angioletti; Marilena Mister; Simona Buelli; Maria Bonomelli; Peter Mundel; Karlhans Endlich; Andrea Remuzzi; Giuseppe Remuzzi
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

5.  MicroRNA-324-3p promotes renal fibrosis and is a target of ACE inhibition.

Authors:  Daniela Macconi; Susanna Tomasoni; Paola Romagnani; Piera Trionfini; Fabio Sangalli; Benedetta Mazzinghi; Paola Rizzo; Elena Lazzeri; Mauro Abbate; Giuseppe Remuzzi; Ariela Benigni
Journal:  J Am Soc Nephrol       Date:  2012-07-19       Impact factor: 10.121

6.  Angiotensin II depolarizes podocytes in the intact glomerulus of the Rat.

Authors:  J Gloy; A Henger; K G Fischer; R Nitschke; P Mundel; M Bleich; P Schollmeyer; R Greger; H Pavenstädt
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

7.  The role of renin angiotensin system inhibition in kidney repair.

Authors:  Irene M van der Meer; Paolo Cravedi; Giuseppe Remuzzi
Journal:  Fibrogenesis Tissue Repair       Date:  2010-05-04

8.  Angiotensin II contributes to diabetic renal dysfunction in rodents and humans via Notch1/Snail pathway.

Authors:  Elena Gagliardini; Norberto Perico; Paola Rizzo; Simona Buelli; Lorena Longaretti; Luca Perico; Susanna Tomasoni; Carla Zoja; Daniela Macconi; Marina Morigi; Giuseppe Remuzzi; Ariela Benigni
Journal:  Am J Pathol       Date:  2013-05-23       Impact factor: 4.307

9.  Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment.

Authors:  Adam Whaley-Connell; Javad Habibi; Ravi Nistala; Shawna A Cooper; Poorna R Karuparthi; Melvin R Hayden; Nathan Rehmer; Vincent G DeMarco; Bradley T Andresen; Yongzhong Wei; Carlos Ferrario; James R Sowers
Journal:  Hypertension       Date:  2008-01-02       Impact factor: 10.190

10.  Hyperbaric oxygen treatment augments the efficacy of cilazapril and simvastatin regimens in an experimental nephrotic syndrome model.

Authors:  Alper Sonmez; Mahmut Ilker Yilmaz; Ahmet Korkmaz; Turgut Topal; Kayser Caglar; Ayper Kaya; Tayfun Eyileten; Mujdat Yenicesu; Yusuf Oguz; Seref Basal; Osman Metin Ipcioglu; Abdulgaffar Vural
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.